# Metabolic Profile as a Predictor of No-reflow in Diabetic Patients

> **NCT04835207** · — · UNKNOWN · sponsor: **El Zahraa Gamal** · enrollment: 120 (estimated)

## Conditions studied

- Acute Myocardial Infarction (AMI)

## Interventions

- **OTHER:** 1- LDL-C (low-density lipoprotein cholesterol)| and HDL-C(high-density lipoprotein cholesterol) Ratio. 2- Glycemia will be assessed : RBS ( random blood sugar ) . 3- S

## Key facts

- **NCT ID:** NCT04835207
- **Lead sponsor:** El Zahraa Gamal
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04
- **Primary completion:** 2022-04
- **Final completion:** 2022-04
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2021-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04835207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04835207, "Metabolic Profile as a Predictor of No-reflow in Diabetic Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04835207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*